Fundz

Nuritas™ Raises $45 Million To Scale Its Peptide Discovery Platform And Expand Globally

PRIVATENov 11, 2021

Amount Raised

$45 Million

Round Type

Funding Round

BiotechnologyData And Analytics

Investors

Marc Benioff Family Office

Description

Nuritas, a biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million USD Series B funding round. The investment, led by Chicago-based Cleveland Avenue, LLC, includes Grosvenor’s Wheatsheaf Group, the European Circular Bioeconomy Fund (ECBF), Singapore-based Vertex Holdings, Nutresa Ventures/ Veronorte and CJ. Cultivian Sandbox Ventures and VisVires New Protein, who led previous rounds, also participated. Other early investors include U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi

Quick answer

Nuritas raised $45 Million in a Funding Round round, dated November 11, 2021. Investors: Marc Benioff Family Office.

How much did Nuritas raise?
Nuritas raised $45 Million in a Funding Round round on November 11, 2021.
Who invested in Nuritas?
Marc Benioff Family Office is named as investors in this round.
What does Nuritas do?
Nuritas is revolutionizing the discovery of novel, natural and scientifically proven bioactive ingredients that enable their partners to create better or new product solutions for their customers.
Who are the decision-makers at Nuritas?
Fundz holds 1 contact at Nuritas. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Data And Analytics and Biotechnology around the same time

Companies in the same sectors as Nuritas that raised within 45 days of this round, from Fundz verified event records.

  • Nabla Bio raised $11M (Seed) on December 6, 2021.
  • medimaps group S.A raised $20M (Funding Round) on December 1, 2021.
  • Stilla Technologies raised an undisclosed amount on November 23, 2021.
  • Cardurion Pharmaceuticals raised an undisclosed amount on October 27, 2021.
  • American Bitcoin raised $18M on October 20, 2021.
  • Envisagenics raised $19M on October 19, 2021.

Who to call at Nuritas, and when

A new round usually means Nuritas is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nuritas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nuritas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuritas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuritas

About

Nuritas is revolutionizing the discovery of novel, natural and scientifically proven bioactive ingredients that enable their partners to create better or new product solutions for their customers. The company’s disruptive computational approach to discovery uses artificial intelligence, deep learning, and genomics to rapidly and efficiently predict and then unlock the most health-benefiting components hidden within plants and natural food sources, called peptides. Nuritas has since established the world’s largest peptide knowledge base. Through its discoveries, Nuritas wants to firstly manage and improve human health and secondly help make our food system more sustainable by replacing current unwanted ingredients and molecules with more natural and sustainable ones.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuritas raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Nuritas's next move

See what Strategic adds

Nuritas raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.